Annual Accounts Receivable
N/A
December 31, 2023
Summary
- ENTO annual accounts receivable is not available.
Performance
ENTO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 1, 2024
Summary
- ENTO quarterly accounts receivable is not available.
Performance
ENTO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ENTO Accounts Receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
ENTO Accounts Receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time |
Entero Therapeutics Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Jun 2020 | - | $36.80 K(-78.8%) |
Sep 2017 | - | $173.60 K(+8.5%) |
Jun 2017 | - | $160.00 K(-33.3%) |
Mar 2017 | - | $239.90 K(+18.4%) |
Dec 2016 | $202.70 K | $202.70 K(-19.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2016 | - | $250.50 K(-26.7%) |
Jun 2016 | - | $341.60 K(-68.5%) |
Mar 2016 | - | $1.08 M(+0.8%) |
Dec 2015 | $1.07 M(+150.7%) | $1.07 M |
Dec 2014 | $428.80 K | - |
FAQ
- What is the all time high annual accounts receivable for Entero Therapeutics?
- What is the all time high quarterly accounts receivable for Entero Therapeutics?
What is the all time high annual accounts receivable for Entero Therapeutics?
Entero Therapeutics all-time high annual accounts receivable is $1.07 M
What is the all time high quarterly accounts receivable for Entero Therapeutics?
Entero Therapeutics all-time high quarterly accounts receivable is $1.08 M